Ben Franklin Technology Partners, December 1, 2008–Applied Computational Technologies is developing a groundbreaking method for refining the speed and accuracy of radiation treatment planning. 

(L-R) Andy Holland, co-founder and CTO; Kathy Blum, CEO; Jay McClatchey, co-founder and vice president; Steve Morrisson, senior software engineer.

Earlier this year, Kathy Blum started looking around for opportunities to apply her more than 20 years of experience in the medical device and service industry. At the time, the idea of joining a small startup company in central Pennsylvania wasn't at the top of her list.

Six months later—as president and CEO of Applied Computational Technologies (ACT)—Blum is convinced she has hitched her wagon to a rising star shining new light on radiation treatments for cancer patients. Windber-based ACT is developing a groundbreaking method for refining the speed and accuracy of radiation treatment planning. Since hiring Blum in May 2008, the company has also secured significant private investment through BlueTree Allied Angels of Pittsburgh and Golden Seeds of Philadelphia, New York and Boston, and is prepared to complete clinical testing in the second quarter of 2009.

Click here to read the entire article at Ben Franklin Technology Partners.